Ubiquitination-deubiquitination by the TRIM27-USP7 complex regulates tumor necrosis factor alpha-induced apoptosis

Molecular and Cellular Biology

Volumn 33, Issue 24, 2013, Pages 4971-4984

  Zaman, Mohammad Mahabub Uz ^a,b   Nomura, Teruaki ^a,b   Takagi, Tsuyoshi ^a,c   Okamura, Tomoo ^a,d   Jin, Wanzhu ^a,e   Shinagawa, Toshie ^a,b   Tanaka, Yasunori ^a   Ishii, Shunsuke ^a,b  

^a RIKEN TSUKUBA INSTITUTE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

^d TORAY INDUSTRIES INC   (Japan)

^e INSTITUTE OF ZOOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; CYCLOHEXIMIDE; DEUBIQUITINASE; MULTIPROTEIN COMPLEX; PEPTIDES AND PROTEINS; RECEPTOR INTERACTING PROTEIN 1; TRIM27 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN SPECIFIC PROTEASE 7; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; NUCLEAR PROTEIN; POLYUBIQUITIN; PROTEIN SYNTHESIS INHIBITOR; RALBP1 PROTEIN, MOUSE; TRIM27 PROTEIN, MOUSE; USP7 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEUBIQUITINATION; EMBRYO; EMBRYONIC STEM CELL; EXON; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; NUCLEAR EXPORT SIGNAL; PRIORITY JOURNAL; PROTEIN MODIFICATION; RING FINGER MOTIF; UBIQUITINATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; FIBROBLAST; HEK293 CELL LINE; HEPG2 CELL LINE; KNOCKOUT MOUSE; LIVER CELL; METABOLISM; MITOCHONDRION; PHYSIOLOGY; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; CELL STRAIN HEK293; CELL STRAIN HEPG2;

ANIMALS; APOPTOSIS; CYCLOHEXIMIDE; DNA-BINDING PROTEINS; FIBROBLASTS; GTPASE-ACTIVATING PROTEINS; HEK293 CELLS; HEP G2 CELLS; HEPATOCYTES; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA; NUCLEAR PROTEINS; POLYUBIQUITIN; PROTEIN MULTIMERIZATION; PROTEIN SYNTHESIS INHIBITORS; PROTEIN TRANSPORT; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN-SPECIFIC PROTEASES; UBIQUITINATION;

EID: 84891434091     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00465-13     Document Type: Article

References (49)

1. Meroni G, Diez-Roux G. 2005. TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. Bioessays 27:1147-1157.
2. Joazeiro CA, Weissman AM. 2000. RING finger proteins: mediators of ubiquitin ligase activity. Cell 102:549-552.
3. Massiah MA, Simmons BN, Short KM, Cox TC. 2006. Solution structure of the RBCC/TRIM B-box1 domain of human MID1: B-box with a RING. J. Mol. Biol. 358:532-545.
4. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, Riganelli D, Zanaria E, Messali S, Cainarca S, Guffanti A, Minucci S, Pelicci PG, Ballabio A. 2001. The tripartite motif family identifies cell compartments. EMBO J. 20:2140-2151.
5. Ozato K, Shin DM, Chang TH, Morse HC, III. 2008. TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 8:849-860.
6. Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, Jung JU. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-920.
7. Shi M, Deng W, Bi E, Mao K, Ji Y, Lin G, Wu X, Tao Z, Li Z, Cai X, Sun S, Xiang C, Sun B. 2008. TRIM30α negatively regulates TLRmediated NF-κB activation by targeting TAB2 and TAB3 for degradation. Nat. Immunol. 9:369-377.
8. Tsuchida T, Zou J, Saitoh T, Kumar H, Abe T, Matsuura Y, Kawai T, Akira S. 2010. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 33:765-776.
9. Arimoto K, Funami K, Saeki Y, Tanaka K, Okawa K, Takeuchi O, Akira S, Murakami Y, Shimotohno K. 2010. Polyubiquitin conjugation to NEMO by tripartite motif protein 23 (TRIM23) is critical in antiviral defense. Proc. Natl. Acad. Sci. U. S. A. 107:15856-15861.
10. Takahashi M, Ritz J, Cooper GM. 1985. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 42:581-588.
11. Shimono Y, Murakami H, Kawai K, Wade PA, Shimokata K, Takahashi M. 2003. Mi-2ß associates with BRG1 and RET finger protein at the distinct regions with transcriptional activating and repressing abilities. J. Biol. Chem. 278:51638-51645.
12. Krützfeldt M, Ellis M, Weekes DB, Bull JJ, Eilers M, Vivanco MD, Sellers WR, Mittnacht S. 2005. Selective ablation of retinoblastoma protein function by the RET finger protein. Mol. Cell 18:213-224.
13. Harbers M, Nomura T, Ohno S, Ishii S. 2001. Intracellular localization of the Ret finger protein depends on a functional nuclear export signal and protein kinase C activation. J. Biol. Chem. 276:48596-48607.
14. Zha J, Han KJ, Xu LG, He W, Zhou Q, Chen D, Zhai Z, Shu HB. 2006. The Ret finger protein inhibits signaling mediated by the noncanonical and canonical IκB kinase family members. J. Immunol. 176:1072-1080.
15. Chen G, Goeddel DV. 2002. TNF-R1 signaling: a beautiful pathway. Science 296:1634-1635.
16. Croft M. 2009. The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 9:271-285.
17. Vucic D, Dixit VM, Wertz IE. 2011. Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death. Nat. Rev. Mol. Cell Biol. 12:439-452.
18. Pobezinskaya YL, Liu Z. 2012. The role of TRADD in death receptor signaling. Cell Cycle 11:871-876.
19. Micheau O, Tschopp J. 2003. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114:181-190.
20. Mahoney DJ, Cheung HH, Mrad RL, Plenchette S, Simard C, Enwere E, Arora V, Mak TW, Lacasse EC, Waring J, Korneluk RG. 2008. Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activation. Proc. Natl. Acad. Sci. U. S. A. 105:11778-11783.
21. Bertrand MJ, Milutinovic S, Dickson KM, Ho WC, Boudreault A, Durkin J, Gillard JW, Jaquith JB, Morris SJ, Barker PA. 2008. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30:689-700.
22. Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ. 2006. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22:245-257.
23. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, Ma A, Koonin EV, Dixit VM. 2004. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430:694-699.
24. Shembade N, Ma A, Harhaj EW. 2010. Inhibition of NF-κB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 327:1135-1139.
25. Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G. 2003. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature 424:793-796.
26. Brummelkamp TR, Nijman SM, Dirac AM, Bernards R. 2003. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature 424:797-801.
27. Kovalenko A, Chable-Bessia C, Cantarella G, Israël A, Wallach D, Courtois G. 2003. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature 424:801-805.
28. Takagi T, Harada J, Ishii S. 2001. Murine Schnurri-2 is required for positive selection of thymocytes. Nat. Immunol. 2:1048-1053.
29. Bellenger J, Bellenger S, Bataille A, Massey KA, Nicolaou A, Rialland M, Tessier C, Kang JX, Narce M. 2011. High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition. Diabetes 60:1090-1099.
30. Thapa RJ, Basagoudanavar S, Nogusa S, Irrinki K, Mallilankaraman K, Slifker MJ, Beg AA, Madesh M, Balachandran S. 2011. NF-κB protects cells from interferon-γ-induced RIP1-dependent necroptosis. Mol. Cell. Biol. 31:2934-2946.
31. Khan MM, Nomura T, Kim H, Kaul SC, Wadhwa R, Zhong S, Pandolfi PP, Ishii S. 2004. The fusion oncoprotein PML-RARα induces endoplasmic reticulum (ER)-associated degradation of N-CoR and ER stress. J. Biol. Chem. 279:11814-11824.
32. Yamauchi T, Ishidao T, Nomura T, Shinagawa T, Tanaka Y, Yonemura S, Ishii S. 2008. A B-Myb complex containing clathrin and filamin is required for mitotic spindle function. EMBO J. 27:1852-1862.
33. Ramakrishnan P, Baltimore D. 2011. Sam68 is required for both NF-κB activation and apoptosis signaling by the TNF receptor. Mol. Cell 43:167-179.
34. Canning M, Boutell C, Parkinson J, Everett RD. 2004. A RING finger ubiquitin ligase is protected from autocatalyzed ubiquitination and degradation by binding to ubiquitin-specific protease USP7. J. Biol. Chem. 279:38160-38168.
35. Lehmann V, Freudenberg MA, Galanos C. 1987. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med. 165:657-663.
36. Temkin V, Huang Q, Liu H, Osada H, Pope RM. 2006. Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis. Mol. Cell. Biol. 26:2215-2225.
37. Dixit E, Boulant S, Zhang Y, Lee AS, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, Nibert ML, Superti-Furga G, Kagan JC. 2010. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141:668-681.
38. Hu M, Li P, Li M, Li W, Yao T, Wu JW, Gu W, Cohen RE, Shi Y. 2002. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 111:1041-1054.
39. Fernández-Montalván A, Bouwmeester T, Joberty G, Mader R, Mahnke M, Pierrat B, Schlaeppi JM, Worpenberg S, Gerhartz B. 2007. Biochemical characterization of USP7 reveals post-translational modification sites and structural requirements for substrate processing and subcellular localization. FEBS J. 274:4256-4270.
40. Colland F, Formstecher E, Jacq X, Reverdy C, Planquette C, Conrath S, Trouplin V, Bianchi J, Aushev VN, Camonis J, Calabrese A, Borg-Capra C, Sippl W, Collura V, Boissy G, Rain JC, Guedat P, Delansorne R, Daviet L. 2009. Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Mol. Cancer Ther. 8:2286-2295.
41. Dynek JN, Goncharov T, Dueber EC, Fedorova AV, Izrael-Tomasevic A, Phu L, Helgason E, Fairbrother WJ, Deshayes K, Kirkpatrick DS, Vucic D. 2010. c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J. 29:4198-4209.
42. Li M, Brooks CL, Kon N, Gu W. 2004. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell 13:879-886.
43. Marchenko ND, Wolff S, Erster S, Becker K, Moll UM. 2007. Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J. 26:923-934.
44. Uchil PD, Quinlan BD, Chan WT, Luna JM, Mothes W. 2008. TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. PLoS Pathog. 4:e16. doi:10.1371/journal.ppat.0040016.
45. Zapata JM, Pawlowski K, Haas E, Ware CF, Godzik A, Reed JC. 2001. A diverse family of proteins containing tumor necrosis factor receptorassociated factor domains. J. Biol. Chem. 276:24242-24252.
46. Yamauchi K, Wada K, Tanji K, Tanaka M, Kamitani T. 2008. Ubiquitination of E3 ubiquitin ligase TRIM5 alpha and its potential role. FEBS J. 275:1540-1555.
47. Dho SH, Kwon KS. 2003. The Ret finger protein induces apoptosis via its RING finger-B box-coiled-coil motif. J. Biol. Chem. 278:31902-31908.
48. Cai X, Srivastava S, Sun Y, Li Z, Wu H, Zuvela-Jelaska L, Li J, Salamon RS, Backer JM, Skolnik EY. 2011. Tripartite motif containing protein 27 negatively regulates CD4 T cells by ubiquitinating and inhibiting the class II PI3K-C2ß;. Proc. Natl. Acad. Sci. U. S. A. 108:20072-20077.
49. Srivastava S, Cai X, Li Z, Sun Y, Skolnik EY. 2012. Phosphatidylinositol-3-kinase C2ß and TRIM27 function to positively and negatively regulate IgE receptor activation of mast cells. Mol. Cell. Biol. 32:3132-3139.